Aurobindo Pharma Limited (NSE :AUROPHARMA) Q3 2022 Earnings Concall Feb. 10, 2022, Corporate Participants: Arvind Bothra -- Investor Relations Department Santhanam Subramanian
(AUROPHARMA)
XNSE:AUROPHARMA, XBOMAUROPHARMA
Earnings: Aurobindo Pharma results in Q2 2022
Aurobindo Pharma (NSE: AUROPHARMA) reported its second-quarter 2022 earnings results today. The company had a consolidated net profit of ₹696.71 crores with
Aurobindo Pharma Ltd (AUROPHARMA) Q3 FY21 Earnings Concall Transcript
Aurobindo Pharma Ltd (NSE:AUROPHARMA) Q3 FY21 earnings concall dated Feb. 10, 2021. Corporate Participants: Krishna Kiran -- Manager of Investor Relations Santhanam